These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 24995794)

  • 21. Treatment of osteoporosis: whom, how and for how long?
    Dede AD; Callan M
    Br J Hosp Med (Lond); 2018 May; 79(5):259-264. PubMed ID: 29727238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Future therapeutic targets in osteoporosis.
    Deal C
    Curr Opin Rheumatol; 2009 Jul; 21(4):380-5. PubMed ID: 19461517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of denosumab on bone mineral density and bone turnover in postmenopausal women.
    Wensel TM; Iranikhah MM; Wilborn TW
    Pharmacotherapy; 2011 May; 31(5):510-23. PubMed ID: 21923432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Update and perspectives of anabolic therapies for osteoporosis].
    Endo I; Matsumoto T
    Clin Calcium; 2012 Mar; 22(3):327-33. PubMed ID: 22370299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New Frontiers in Osteoporosis Therapy.
    Cheng C; Wentworth K; Shoback DM
    Annu Rev Med; 2020 Jan; 71():277-288. PubMed ID: 31509477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New horizons in osteoporosis therapies.
    Harsløf T; Langdahl BL
    Curr Opin Pharmacol; 2016 Jun; 28():38-42. PubMed ID: 26989807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The evolving role of anabolic therapy in the treatment of osteoporosis.
    Cosman F
    Curr Opin Rheumatol; 2019 Jul; 31(4):376-380. PubMed ID: 31090588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emerging therapeutic targets for osteoporosis treatment.
    Chen M; Qiao H; Su Z; Li H; Ping Q; Zong L
    Expert Opin Ther Targets; 2014 Jul; 18(7):817-31. PubMed ID: 24766518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The quest for new drugs to prevent osteoporosis-related fractures.
    de Villiers TJ
    Climacteric; 2017 Apr; 20(2):103-106. PubMed ID: 28286990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New understanding and treatments for osteoporosis.
    Mazziotti G; Bilezikian J; Canalis E; Cocchi D; Giustina A
    Endocrine; 2012 Feb; 41(1):58-69. PubMed ID: 22180055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Osteoporosis: what's new and on the horizon.
    Silva BC; Costa AG; Cusano NE; Bilezikian JP
    Clin Obstet Gynecol; 2013 Dec; 56(4):730-8. PubMed ID: 24036482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of patients at very high risk of osteoporotic fractures through sequential treatments.
    Curtis EM; Reginster JY; Al-Daghri N; Biver E; Brandi ML; Cavalier E; Hadji P; Halbout P; Harvey NC; Hiligsmann M; Javaid MK; Kanis JA; Kaufman JM; Lamy O; Matijevic R; Perez AD; Radermecker RP; Rosa MM; Thomas T; Thomasius F; Vlaskovska M; Rizzoli R; Cooper C
    Aging Clin Exp Res; 2022 Apr; 34(4):695-714. PubMed ID: 35332506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigational anabolic agents for the treatment of osteoporosis: an update on recent developments.
    Dede AD; Makras P; Anastasilakis AD
    Expert Opin Investig Drugs; 2017 Oct; 26(10):1137-1144. PubMed ID: 28836858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Established and forthcoming drugs for the treatment of osteoporosis.
    Lems WF; den Heijer M
    Neth J Med; 2013 May; 71(4):188-93. PubMed ID: 23723112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current treatment approaches to osteoporosis - 2013.
    Honig S; Rajapakse CS; Chang G
    Bull Hosp Jt Dis (2013); 2013; 71(3):184-8. PubMed ID: 24151942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New developments in the treatment of osteoporosis.
    Eriksen EF; Halse J; Moen MH
    Acta Obstet Gynecol Scand; 2013 Jun; 92(6):620-36. PubMed ID: 22646526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Anabolic treatment for osteoporosis: PTH treatment].
    Kaji H; Sugimoto T
    Clin Calcium; 2006 Sep; 16(9):1480-85. PubMed ID: 16951472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological Therapy of Osteoporosis: What's New?
    Iolascon G; Moretti A; Toro G; Gimigliano F; Liguori S; Paoletta M
    Clin Interv Aging; 2020; 15():485-491. PubMed ID: 32273690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of anabolic agents in the treatment of osteoporosis: a clinical update.
    Inderjeeth CA; Inderjeeth DC
    Curr Opin Endocrinol Diabetes Obes; 2024 Aug; 31(4):157-163. PubMed ID: 38752851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bi-directionally selective bone targeting delivery for anabolic and antiresorptive drugs: a novel combined therapy for osteoporosis?
    Liu J; Zhang H; Dong Y; Jin Y; Hu X; Cai K; Ma J; Wu G
    Med Hypotheses; 2014 Dec; 83(6):694-6. PubMed ID: 25459136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.